Therefore, the inhibition of HSPs appears to be of great interest to improve the efficiency of chemotherapy and the disease outcome, and a large number of inhibitors targeting HSP are currently developed or clinically tested for cancer treatment [15]. This evidence concerns the gene HSP90B2P and cancer.